ArticleInnovations in pharmacy2022

Concerns with Patient Reported Outcome Measurement and Value Claims for Therapy Response: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM).

Paul C LangleyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.